BioSpace News Archive

The University of Illinois today announced that Monsanto, a global agriculture company headquartered in St. Louis, and The Climate Corporation, a subsidiary of Monsanto have opened the Monsanto Innovation Center at the University of Illinois Research Park.

The employees received, in the aggregate, options to purchase 92,793 shares of Sarepta’s common stock.

With the upgrade to the OTCQB Venture Market, the shares will continue to trade under the ticker symbol “KNBIF.”

The notice concerns the following two transparency notifications:

Nuvectra intends to use the net proceeds from this offering to fund the expansion of product development and commercialization activities, as well as for general corporate purposes.

The abstract showcases the potential of Actinium’s AWE Technology Platform, specifically, the ability of actinium-225 to enhance the in vivo efficacy of daratumumab, a CD38 targeting therapy that is marketed by Johnson & Johnson as Darzalex®.

An international meta-analysis of clinical experience in patients who received an endoAVF for hemodialysis access was presented today at LINC 2018.

ClearFlow announced that the cover of the January 2018 issue of The Annals of Thoracic Surgery features a review article that elucidates the biological mechanisms by which retained shed mediastinal blood can trigger postoperative atrial fibrillation (POAF) in susceptible individuals as well as how this could represent a new target for prevention of POAF.

Dr. Ernest Loumaye extends his gratitude to Dr Frank Verwiel and the Office of the CEO for overseeing the operations of the Company during his absence.

Financial and operating highlights during the third quarter of fiscal 2018 include: